findmyKOL
Clinical trialNCT05304611CompletedPhase 2Interventional

Anti-malaria MAb in Malian Children

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment365MalariaPlasmodium Falciparum Infection
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Kassoum Kayentao, MD, MPH, PhD

    Faculté de Médecine Pharmacie d'Odontostomatologie (FMPOS)

    Principal Investigator
  • Peter Crompton, MD, MPH

    National Institutes of Health (NIH)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Mali
  • Kalifabougou Mrtc Clinic

    Kalifabougou, Koulikoro, Mali

  • Torodo Mrtc Clinic

    Torodo, Koulikoro, Mali

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Mar 2022
Primary completion
20 Apr 2024
Completion
20 Apr 2024
Last update posted
10 Jul 2025
Registered enrollment
365
Registry id
NCT05304611

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.